Diferencia entre revisiones de «Pyrantel Pamoate»
Sin resumen de edición |
|||
| Línea 1: | Línea 1: | ||
==Administration== | ==Administration== | ||
*Type: Antiparasitic | *Type: [[Antiparasitic]] | ||
*Dosage Forms: | *Dosage Forms: | ||
*Routes of Administration: Oral | *Routes of Administration: Oral | ||
*Common Trade Names: | *Common Trade Names: | ||
==Adult Dosing== | ==Adult Dosing== | ||
Revisión del 17:59 28 mar 2017
Administration
- Type: Antiparasitic
- Dosage Forms:
- Routes of Administration: Oral
- Common Trade Names:
Adult Dosing
- 11mg/kg once
Pediatric Dosing
- > 2yo: 11mg/kg once
Special Populations
- Pregnancy Rating: C
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing:
- Hepatic dosing:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
- Nausea/vomiting, diarrhea
- Headache, dizziness, somnolence
Pharmacology
- Half-life:
- Metabolism:
- Excretion: Fecal
Mechanism of Action
- depolarizing neuromuscular blocking agent, causes spastic paralysis in the worms
Comments
- Indicated to treat infection with enterobius, ascaris, and other similar worms